Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

Stockholders’ Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended							3 Months Ended			9 Months Ended
	May 31, 2022	Apr. 30, 2022	Mar. 31, 2022	Feb. 28, 2022	Jan. 31, 2022	Aug. 31, 2021	Jan. 31, 2021	Sep. 30, 2022	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Common Stock shares, Outstanding								14,629,217			14,629,217		9,914,158
Proceeds from Warrant Exercises											$ 4
Stock-based compensation											1,038	$ 1,359
2015 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of additional shares authorized							1,000,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)									1,151,000	2,725,000
Common Stock [Member] \| Restricted stock agreement with Maxim Group, LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares agreed to issue						50,000
Vesting period						12 months
Stock-based compensation								$ 18,000			$ 71,000
JT Pharmaceuticals [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)					51,021
Milestone Payment					$ 100,000
Pre-Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	1,289,796	1,300,000	974,242						974,242
Proceeds from Warrant Exercises	$ 1,290	$ 1,300	$ 1,000
February 2022 Offerings [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)				1,100,000
Proceeds from sale of common stock				$ 5,000
February 2022 Offerings [Member] \| Pre-Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued				2,274,242
Exercise price of warrants (in dollars per share)				$ 0.001
February 2022 Offerings [Member] \| Unregistered prefunded warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued				1,289,796
Exercise price of warrants (in dollars per share)				$ 0.00
February 2022 Offerings [Member] \| Unregistered five year and six month warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued				4,664,038
Exercise price of warrants (in dollars per share)				$ 1.14
January 2021 Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)							2,725,000
Number of warrants issued							2,725,000
Exercise price of warrants (in dollars per share)							$ 3.55
Proceeds from sale of common stock							$ 8,800